posteditor

posteditor

Quest Diagnostics Prices $500 Million of Senior Notes

B SECAUCUS, N.J., April 27, 2026 /PRNewswire/ — Quest Diagnostics Incorporated (NYSE: DGX) (the “Company”), a leader in diagnostic information services, today announced the pricing of a public offering of $500 million aggregate principal amount of its 5.000% senior notes due 2036…